The DOI matches its Crossref record; 43 of the 45 references it cites were found in a registry or an index.
Educational Intervention Improves Anticoagulation Control in Atrial Fibrillation Patients: The TREAT Randomised Trial
Open accessAbstract
BACKGROUND: Stroke prevention in atrial fibrillation (AF), most commonly with warfarin, requires maintenance of a narrow therapeutic target (INR 2.0 to 3.0) and is often poorly controlled in practice. Poor patient-understanding surrounding AF and its treatment may contribute to the patient's willingness to adhere to recommendations. METHOD: A theory-driven intervention, developed using patient interviews and focus groups, consisting of a one-off group session (1-6 patients) utilising an "expert-patient" focussed DVD, educational booklet, self-monitoring diary and worksheet, was compared in a randomised controlled trial (ISRCTN93952605) against usual care, with patient postal follow-ups at 1, 2, 6, and 12-months. Ninety-seven warfarin-naïve AF patients were randomised to intervention (n=46, mean age (SD) 72.0 (8.2), 67.4% men), or usual care (n=51, mean age (SD) 73.7 (8.1), 62.7% men), stratified by age, sex, and recruitment centre. Primary endpoint was time within therapeutic range (TTR); secondary endpoints included knowledge, quality of life, anxiety/depression, beliefs about medication, and illness perceptions. MAIN FINDINGS: Intervention patients had significantly higher TTR than usual care at 6-months (76.2% vs. 71.3%; p=0.035); at 12-months these differences were not significant (76.0% vs. 70.0%; p=0.44). Knowledge increased significantly across time (F (3, 47) = 6.4; p<0.01), but there were no differences between groups (F (1, 47) = 3.3; p = 0.07). At 6-months, knowledge scores predicted TTR (r=0.245; p=0.04). Patients' scores on subscales representing their perception of the general harm and overuse of medication, as well as the perceived necessity of their AF specific medications predicted TTR at 6- and 12-months. CONCLUSIONS: A theory-driven educational intervention significantly improves TTR in AF patients initiating warfarin during the first 6-months. Adverse clinical outcomes may potentially be reduced by improving patients' understanding of the necessity of warfarin and reducing their perception of treatment harm. Improving education provision for AF patients is essential to ensure efficacious and safe treatment. The trial is registered with Current Controlled Trials, ISRCTN93952605, and details are available at www.controlled-trials.com/ISRCTN93952605.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Several patient-information tools have been developed, largely focusing on oral anticoagulation.[1013][1014][1015][1016]”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [1014]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Hospital Anxiety and Depression Scale
Zigmond, A. S., & Snaith, R. P. (1983) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1983.tb09716.x · Cited by 47,139
Depression and quality of life in older persons: A review
Sivertsen, H., Bjørkløf, G. H., Engedal, K., Selbæk, G., & Helvik, A.-S. (2015) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000437299 · Cited by 14,152
Adherence to Long-Term Therapies: Evidence for Action
Geest, S. D., & Sabate, E. J. (2003) · European Journal of Cardiovascular Nursing · doi:10.1016/s1474-5151(03)00091-4 · Cited by 6,310
Guidelines for the management of atrial fibrillation
Authors/Task Force Members, Camm, A. J., Kirchhof, P. F., Lip, G. Y. H., Schotten, U., Savelieva, I., Ernst, S., Gelder, I. C. V., Al‐Attar, N., Hindricks, G., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq278 · Cited by 5,924
Self-citationHart, R. G., Pearce, L. A., & Aguilar, M. I. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-12-200706190-00007 · Cited by 4,793
The Brief Illness Perception Questionnaire
Broadbent, E., Petrie, K. J., Main, J., & Weinman, J. (2006) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2005.10.020 · Cited by 3,431
Horne, R., Weinman, J. A., & Hankins, M. C. (1999) · Psychology and Health · doi:10.1080/08870449908407311 · Cited by 2,383
A Method to Determine the Optimal Intensity of Oral Anticoagulant Therapy
Rosendaal, F. R., Cannegieter, S. C., van der Meer, F. J. M., & Briët, E. (1993) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1651587 · Cited by 2,070
Hylek, E. M., Evans‐Molina, C., Shea, C., Henault, L. E., & Regan, S. (2007) · Circulation · doi:10.1161/circulationaha.106.653048 · Cited by 1,063
Underuse of Oral Anticoagulants in Atrial Fibrillation: A Systematic Review
Ogilvie, I. M., Newton, N., Welner, S. A., Cowell, W., & Lip, G. Y. H. (2010) · The American Journal of Medicine · doi:10.1016/j.amjmed.2009.11.025 · Cited by 929
Self-citation
Flagged first, then by citations
2 of the 45 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- R Horne, 1999, The Beliefs about Medicines Questionairre: the development and evaluation of a new method for assessing the cognitive representation of medication, Psychol Health, 14, 1, 10.1080/08870449908407311 · DOI
Cited by
Sorted by citations
Items 101–200 of 209
Lip, G. Y. H., Lane, D. A., & Potpara, T. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx807 · Cited by 14
Self-citationSim, V., & Galbraith, K. J. (2020) · Patient Education and Counseling · doi:10.1016/j.pec.2020.05.003 · Cited by 13
Desteghe, L., Delesie, M., Knaepen, L., Önder, R., Verbeeck, J., Dendale, P., Phlips, T., Haemers, P., Saenen, J. B., Ector, J., et al. (2024) · EP Europace · doi:10.1093/europace/euae211 · Cited by 13
Oh, Y.-H., & Hwang, S. Y. (2021) · International Journal of Nursing Practice · doi:10.1111/ijn.12902 · Cited by 13
Yiu, A. W. P., & Bajorek, B. V. (2019) · Therapeutic Advances in Drug Safety · doi:10.1177/2042098619847423 · Cited by 13
da Costa, J. M., Marcolino, M. S., Torres, H. D. C., de Resende, R. E., de Souza, R. P., Barbosa, H. C., Ribeiro, D. D., & Martins, M. A. P. (2019) · Medicine · doi:10.1097/md.0000000000015829 · Cited by 12
Bhat, A., Karthikeyan, S., Chen, H. H. L., Gan, G. C. H., Denniss, A. R., & Tan, T. C. (2023) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2023.01.020 · Cited by 12
Ivany, E., Lane, D. A., Dan, G., Doehner, W., Farkowski, M. M., Iliodromitis, K. E., Lenarczyk, R., & Potpara, T. (2020) · EP Europace · doi:10.1093/europace/euaa423 · Cited by 12
Self-citationTransitions in Atrial Fibrillation Care: A Systematic Review
Rush, K. L., Burton, L., Ollivier, R., Wilson, R. E., Loewen, P. S., Janke, R., Schaab, K., Lukey, A., & Galloway, C. S. L. (2019) · Heart Lung and Circulation · doi:10.1016/j.hlc.2019.11.022 · Cited by 11
Lin, S., Chen, Y., Kang, H.-C., Wu, Y.-J., Chen, P.-Z., Wu, C., Lin, C.-S., Wu, F. L., Shen, L., Huang, Y., et al. (2021) · Postgraduate Medicine · doi:10.1080/00325481.2021.1949212 · Cited by 11
Sheils, E., Tillett, W. L., James, D. H., Brown, S. L., Dack, C., Family, H. E., & Chapman, S. (2023) · Health Psychology · doi:10.1037/hea0001316 · Cited by 13
Minimizing the risk of hemorrhagic stroke during anticoagulant therapy for atrial fibrillation
Zoppellaro, G., Granziera, S., Jose, S. P., Denas, G., Bracco, A., Iliceto, S., & Pengo, V. (2015) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2015.1024222 · Cited by 11
Franchi, C., Antoniazzi, S., Ardoino, I., Proietti, M., Marcucci, M., Santalucia, P., Monzani, V., Mannucci, P. M., & Nobili, A. (2019) · The American Journal of Medicine · doi:10.1016/j.amjmed.2019.03.052 · Cited by 11
Marcatto, L. R., Sacilotto, L., Bueno, C. T., Facin, M., Strunz, C. M. C., Darrieux, F., Scanavacca, M., Krieger, J. E., Pereira, A. C., & Santos, P. C. J. L. (2016) · BMC Cardiovascular Disorders · doi:10.1186/s12872-016-0405-1 · Cited by 11
Souza-Silva, M. V. R., Domingues, M. L. D. P., Chagas, V. S., Pereira, D. N., de Sá, L. C., Almeida, M. S. S., Sales, T. L. S., Raposo, M. C., Guimarães, N. S., Oliveira, J. A. D. Q., et al. (2022) · BMC Family Practice · doi:10.1186/s12875-022-01647-5 · Cited by 11
Feldeisen, D., Alexandris-Souphis, C., Haymart, B., Gu, X., Perry, L., Watts, S., Kozlowski, R., Kozłowski, J., Froehlich, J. B., Barnes, G. D., et al. (2022) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-022-02718-1 · Cited by 10
Clarkesmith, D. E., Pattison, H. M., Xuereb, C. B., & Lane, D. A. (2016) · Healthcare · doi:10.3390/healthcare4010010 · Cited by 10
Self-citationShiga, T., Kimura, T., Fukushima, N., Yoshiyama, Y., Iwade, K., Mori, F., Ajiro, Y., Haruta, S., Yamada, Y., Sawada, E., et al. (2021) · Journal of Arrhythmia · doi:10.1002/joa3.12532 · Cited by 10
Phrommintikul, A., Nathisuwan, S., Gunaparn, S., Krittayaphong, R., Wongcharoen, W., Sehmi, S., Mehta, S. P., Winkles, N., Brocklehurst, P., Mathers, J. M., et al. (2021) · BMJ Open · doi:10.1136/bmjopen-2021-051987 · Cited by 10
Self-citationRacial and Ethnic Disparities in Stroke Prevention for Atrial Fibrillation
Calvert, P. A. R., Tamirisa, K. P., Al‐Ahmad, A., Lip, G. Y. H., & Gupta, D. (2022) · The American Journal of Medicine · doi:10.1016/j.amjmed.2022.11.009 · Cited by 9
Self-citationRakhshan, M., Najafi, H., & Valizadeh, G. A. (2019) · Journal of Caring Sciences · doi:10.15171/jcs.2019.012 · Cited by 10
Warfarin Therapy and Improved Anticoagulation Control by Patient Self-Management
Ritchie, L. A., Penson, P. E., & Lane, D. A. (2019) · Thrombosis and Haemostasis · doi:10.1055/s-0039-1696982 · Cited by 9
Self-citationWang, M., Swinton, M. E., Troyan, S., Ho, J. M.-W., Siegal, D. M., Mbuagbaw, L. C. E., Thabane, L., & Holbrook, A. M. (2022) · Journal of Evaluation in Clinical Practice · doi:10.1111/jep.13665 · Cited by 8
Esteve‐Pastor, M. A., Ortiz, M. R., Muñiz, J., Roldán‐Rabadán, I., Otero, D., Cequier, A. R., Bertoméu, V., Badimón, L., Anguita, M. P., Lip, G. Y. H., et al. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.856222 · Cited by 8
Self-citationDzeshka, M. S., & Lip, G. Y. H. (2014) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2015.973847 · Cited by 8
Self-citationFamilial amyloid polyneuropathy: elaboration of a therapeutic patient education programme, “EdAmyl”
Théaudin, M., Cauquil, C. A., Antonini, T., Algalarrondo, V., Labeyrie, C., Ayçaguer, S., Clément, M., Kubezyk, M., Nonnez, G., Morier, A., et al. (2014) · Amyloid · doi:10.3109/13506129.2014.941463 · Cited by 8
Harris, D. E., Thayer, D. S., Wang, T., Brooks, C. J., Murley, G., Gravenor, M. B., Hill, N. R., Lister, S., & Halcox, J. (2019) · European Heart Journal - Cardiovascular Pharmacotherapy · doi:10.1093/ehjcvp/pvz071 · Cited by 8
Rivera‐Caravaca, J. M., Menichelli, D., Pastori, D., Soler‐Espejo, E., Esteve‐Pastor, M. A., Vivas, D., Roldán, I., Anguita, M. P., Ferreiro, J. L., Roldán, V., et al. (2025) · Medicina Clínica · doi:10.1016/j.medcli.2025.107031 · Cited by 7
Rivera‐Caravaca, J. M., Badimón, L., González, I. F., Gómez‐Doblas, J. J., Roca‐Luque, I., Lekuona, I., Jiménez‐Candil, J., Padial, L. R., González‐Juanatey, C., Jambrina, R. C., et al. (2021) · EP Europace · doi:10.1093/europace/euab131 · Cited by 7
de Terline, D. M., Hejblum, G., Fernandez, C., Cohen, A. A., & Antignac, M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0146927 · Cited by 7
Son, Y., & Seo, E. J. (2018) · Research in Gerontological Nursing · doi:10.3928/19404921-20180511-01 · Cited by 7
Patient perception of anticoagulant treatment for stroke prevention (RE-SONANCE study)
Vinereanu, D., Napalkov, D. A., Bergler-Klein, J. K., Benczúr, B., Ciernik, M., Gotcheva, N. N., Medvedchikov, A., Põder, P., Šimić, D., Skride, A., et al. (2020) · Open Heart · doi:10.1136/openhrt-2019-001202 · Cited by 7
Ng, V. W. S., Siu, C., Chiu, P. K. C., Kng, C., Jamieson, E., Wong, I. C. K., & Lam, M. P. S. (2020) · BMC Health Services Research · doi:10.1186/s12913-020-05947-3 · Cited by 6
Inostroza, C. I. F., Ricart, I. F., Cuadra, C. S., Ribó, À. A., Sánchez, M., Cabrera, J., & Puig, B. C.-V. (2015) · PubMed · Cited by 6
Huang, D., Wong, C.-L., Cheng, K.-W., Chan, P., Yue, W., Wong, C., Ho, C. W., Wong, I. C. K., Chan, E. W., & Siu, C. (2018) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2017-135457 · Cited by 6
Hori, K., Okumura, Y., Nagashima, K., Yokoyama, K., Matsumoto, N., Tachibana, E., Kuronuma, K., Oiwa, K., Matsumoto, M., Kojima, T., et al. (2020) · Journal of Cardiology · doi:10.1016/j.jjcc.2020.01.007 · Cited by 6
Roldán, V., Martínez-Montesinos, L., López‐Gálvez, R., García-Tomás, L., Lip, G. Y. H., Rivera‐Caravaca, J. M., & Marín, F. R. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12030487 · Cited by 6
Self-citationPaschoal, E., Gooden, T. E., Olmos, R. D., Lotufo, P. A., Benseñor, I. M., Manaseki‐Holland, S., Lip, G. Y. H., Thomas, G. N., Jolly, K. B., Lancashire, E. R., et al. (2022) · BMC Cardiovascular Disorders · doi:10.1186/s12872-022-02927-9 · Cited by 6
Self-citationErlingsdóttir, H. Ý., Ketilsdóttir, A., Hendriks, J., & Ingadóttir, B. (2023) · Patient Preference and Adherence · doi:10.2147/ppa.s428444 · Cited by 5
Drapkina, O. M., Boytsov, S. A., Golukhova, E. Z., Davtyan, K. V., Drozdova, L. Y., Ipatov, P. V., Калинина, А. М., Martsevich, S. Y., Savchenko, E. D., Kharlap, M. S., et al. (2024) · Primary Health Care (Russian Federation) · doi:10.15829/3034-4123-2024-24 · Cited by 6
Gotsman, I., Ezra, O., Raccah, B. H., Admon, D., Lotan, C., & Ganz, F. D. (2017) · The American Journal of Medicine · doi:10.1016/j.amjmed.2017.02.030 · Cited by 5
Auyeung, V., Patel, J. P., Bartoli-Abdou, J., Vadher, B., Bonner, L., Brown, A. H., Roberts, L. N., Patel, R., & Arya, R. (2016) · BMC Hematology · doi:10.1186/s12878-016-0061-9 · Cited by 5
Metaxas, C., Albert, V., Stahl, M. M. S., Hersberger, K. E., & Arnet, I. (2018) · Drug Healthcare and Patient Safety · doi:10.2147/dhps.s152954 · Cited by 5
Anticoagulant Therapy for Atrial Fibrillation in Real Practice: Problems and Prospects
Skirdenko, Y. P., Николаев, Н. А., Livzan, M. A., & Валерьевич, Е. А. (2019) · Annals of the Russian academy of medical sciences · doi:10.15690/vramn1116 · Cited by 5
Farsad, B. F., Dastan, F., Salamzadeh, J., Moghadamnia, Z., Eskandari, R., & Fahimi, F. (2019) · PubMed Central · doi:10.22037/ijpr.2020.14766.12641 · Cited by 5
Young, J., Nalder, M., Gorelik, A., & Elliott, R. A. (2021) · Pharmacy · doi:10.3390/pharmacy10010003 · Cited by 5
Lloyd, K. E., Hall, L., Ziegler, L. E., Foy, R., Green, S. M. C., MacKenzie, M., Taylor, D. G., & Smith, S. G. (2023) · BMJ Open · doi:10.1136/bmjopen-2023-078703 · Cited by 5
Piran, S., Schulman, S., Salib, M., Delaney, J., Panju, M., & Pai, M. (2017) · Canadian Journal of General Internal Medicine · doi:10.22374/cjgim.v12i3.201 · Cited by 5
Singh, S., Bottois, C., Benmelouka, C., Gutermann, L., & Conort, O. (2021) · Annales Pharmaceutiques Françaises · doi:10.1016/j.pharma.2021.08.007 · Cited by 4
Chang, S., Xu, W., Wu, S., Desteghe, L., Zhang, F., & Zhang, J. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1148524 · Cited by 4
Phrommintikul, A., Nathisuwan, S., Wongcharoen, W., Krittayaphong, R., Gunaparn, S., Wongthanee, A., Mathers, J. M., Jowett, S. M., Jolly, K. B., Lane, D. A., et al. (2024) · JACC Asia · doi:10.1016/j.jacasi.2024.08.011 · Cited by 4
Self-citationCoral and Cnidarian Welfare in a Changing Sea
Weil, E. F., Weil-Allen, A., & Weil, A. (2019) · Animal welfare · doi:10.1007/978-3-030-13947-6_6 · Cited by 4
Cao, Y., Feng, Y.-Y., Du, W., Li, J., Fei, Y.-L., Yang, H., Wang, M., Li, S., Li, X.-J., & Han, B. (2023) · Patient Preference and Adherence · doi:10.2147/ppa.s435592 · Cited by 4
Global voices on atrial fibrillation: South/Southeast Asia
Krittayaphong, R., Phrommintikul, A., Bahuleyan, C. G., Surenthirakumaran, R., Namboodiri, N., Makkar, N., Lordson, J., Sheron, V. A., Uruthirakumar, P., Subaschandran, K., et al. (2024) · Heart Rhythm O2 · doi:10.1016/j.hroo.2024.06.004 · Cited by 4
Self-citationXu, W., Wu, T., Chen, J., Lv, M., Wang, N., Qiu, S., Dai, H., Hu, W., Pei, C., Li, M., et al. (2024) · European Journal of Cardiovascular Nursing · doi:10.1093/eurjcn/zvae092 · Cited by 4
Optimizing stroke prevention in elderly patients with atrial fibrillation
Lip, G. Y. H. (2016) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13480 · Cited by 4
Self-citationAnticoagulation with Warfarin: Roles of Adherence, Social Support and Illness Perception
Koya, S. N. M. V. M. (2019) · INNOVATIONS in pharmacy · doi:10.24926/iip.v10i4.1966 · Cited by 3
Dhore-Patil, A., Crawford, M., Nedunchezhian, S., Hajjar, A. H. E., Mekhael, M., O’Keefe, E. L., Daghar, L., Noujaim, C., Bhatnagar, A., Pottle, C., et al. (2022) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2022.11.016 · Cited by 3
Rivera‐Caravaca, J. M., Viedma, I. V., & Roldán, V. (2016) · Biological Research For Nursing · doi:10.1177/1099800416671211 · Cited by 3
Barrios, V., Egocheaga-Cabello, M. I., Gállego-Culleré, J., Ignacio-García, E., Manzano, L., Martı́n, A., Mateo, J., García, J. P., & Vargas-Ortega, D. (2017) · Revista Clínica Española · doi:10.1016/j.rce.2016.12.011 · Cited by 3
Lo, F. M. W., Wong, E. M. L., & Hong, F. K. W. (2021) · The Journal of Cardiovascular Nursing · doi:10.1097/jcn.0000000000000790 · Cited by 3
Health Literacy Interventions and Outcomes in Patients With Atrial Fibrillation
Lathlean, T. J. H., Kieu, D., Franke, K. B., O’Callaghan, N. J., Boyd, M. A., & Mahajan, R. (2026) · JACC Advances · doi:10.1016/j.jacadv.2026.102667 · Cited by 2
Dabigatran etexilate for venous thromboembolism: a safety evaluation
Brown, R., Lip, G. Y. H., & Gallego, P. (2014) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2014.895321 · Cited by 2
Self-citationBarrios, V., Egocheaga-Cabello, M. I., Gállego-Culleré, J., Ignacio-García, E., Manzano, L., Martı́n, A., Mateo, J., García, J. P., & Vargas-Ortega, D. (2017) · Revista Clínica Española (English Edition) · doi:10.1016/j.rceng.2016.12.007 · Cited by 2
2021 Korean Heart Rhythm Society Guidelines for Stroke Prevention in Atrial Fibrillation
Lee, K. H., Kim, J., Shin, S. Y., & Joung, B. (2021) · Korean Journal of Medicine · doi:10.3904/kjm.2021.96.4.296 · Cited by 2
Batran, R. A., Sabri, N. A., Ali, I., & Fahmy, S. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.889197 · Cited by 2
Dsouza, J. P., Chakrabarty, J., Ramachandran, P., Guddattu, V., Nayak, B. S., & George, A. (2022) · Patient Preference and Adherence · doi:10.2147/ppa.s365585 · Cited by 2
Bhatt, S., McCurdy, C. E., Liew, D., & Russell, D. M. (2018) · Journal of Pharmacy Practice and Research · doi:10.1002/jppr.1430 · Cited by 2
Chen, P.-T., HSIEH, M., Shih-Chang, K., & Wang, T.-J. T. (2022) · Research and theory for nursing practice · doi:10.1891/rtnp-2021-0068 · Cited by 1
Angeli, F., Reboldi, G., Agnelli, G., Ambrosio, G., Capucci, A., Carreras, G., Cavallini, C., Murrone, A., Vaudo, G., Zingarini, G., et al. (2023) · Clinics and Practice · doi:10.3390/clinpract13050105 · Cited by 1
Can, V., Polat, F., Kaya, A. F., Kümet, Ö., Ayhan, G., & Özbek, E. (2026) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000001830 · Cited by 1
Effect of self-management interventions on complications of atrial fibrillation: A clinical trial
Najafi, H., & Rakhshan, M. (2018) · Biomedical Research - India · doi:10.4066/biomedicalresearch.29-17-2680 · Cited by 1
Ginks, M., Lane, D., McGavigan, A. D., & Lip, G. Y. H. (2020) · doi:10.1093/med/9780198746690.003.0346 · Cited by 1
Self-citationEvidence-Based Recommendations
Hussein, M. T. E., & Mikhail, M. (2022) · Dimensions of Critical Care Nursing · doi:10.1097/dcc.0000000000000553 · Cited by 1
Zylla, M. M., Özdemir, B., Hochadel, M., Zeymer, U., Akın, İ., Grau, A., Schneider, S., Alonso, A., Waldecker, B., Süselbeck, T., et al. (2024) · Clinical Research in Cardiology · doi:10.1007/s00392-024-02510-6 · Cited by 1
Jeddou, K. B., Abbassi, A., Mbarka, F. B., Bedoui, Y., Boukhris, I., Baccar, H., Khalfallah, N., & Ouahchi, Z. (2021) · International Journal of Pharmacy Practice · doi:10.1093/ijpp/riab024 · Cited by 1
Ntaios, G., & Sacco, S. (2015) · Internal and Emergency Medicine · doi:10.1007/s11739-015-1221-9 · Cited by 1
Saab, S. M., Algari, A. M., Saab, M. A., Daowd, R. A. A., Almograbi, M. A., Abdulkader, N. Y., Rakhil, K. A., Alrashed, N. M., Albusayyis, R. F., Bismar, B. K., et al. (2025) · Preprints.org · doi:10.20944/preprints202505.0328.v1 · Cited by 1
The Effect of an Educational Intervention on Oral Anticoagulation Therapy Knowledge in Primary Care
Deck, E. (2015) · ValpoScholar (Valparaiso University)
Educación y evaluación del conocimiento del paciente en tratamiento con anticoagulantes orales
Izazola-Conde, C., Majluf‐Cruz, A., Mandoki, J. J., & Molina-Güarneros, J. (2014) · Revista Médica Del Hospital General De México
Innovation in Healthcare Award: change from the front line
Kmietowicz, Z. (2014) · BMJ · doi:10.1136/bmj.g2487
Winston, K. Y. (2016) · Libraries and Cultural Resources (University of Calgary) · doi:10.11575/prism/25981
Anticoagulants for Atrial Fibrillation
Senoo, K., & Lip, G. Y. H. (2017) · Cardiovascular medicine · doi:10.1007/978-3-319-58000-5_9
Self-citationCaldeira, D. (2017) · Current Medical Research and Opinion · doi:10.1080/03007995.2017.1411794
Rejeb, O. B., Brahim, W. B., Ghali, H., Ernez, S., Mahdhaoui, A., & Jeridi, G. (2018) · Annales de Cardiologie et d Angéiologie · doi:10.1016/j.ancard.2018.08.024
Assessment of Anticoagulation Knowledge and Adherence in Patients with Atrial Fibrillation
Obamiro, K. O. (2017) · UTAS Research Repository · doi:10.25959/100.00028460
Patient Feedback on a Warfarin Action Plan Used in a Local Australian Physician Practice Setting
Yiu, A. W. P., Lee, V. W., Ng, K. K., & Bajorek, B. V. (2019) · Therapeutic Innovation & Regulatory Science · doi:10.1177/2168479019865900
Gallagher, C. (2019) · Adelaide Research & Scholarship (AR&S) (University of Adelaide)
Anticoagulation control in patients with atrial fibrillation
Zulkifly, H. H. (2019) · University of Birmingham Institutional Research Archive (University of Birmingham)
Elzeky, M. E. H., Sherief, W., Ellateef, A. A., & Soliman, H. (2015) · Mansoura Nursing Journal · doi:10.21608/mnj.2015.149103
Дешко, М. С., Бойко, С. Л., Вячеславовна, У. И., Гриб, С. Н., Шпак, Н. В., & Александрович, С. В. (2021) · Кардиология в Беларуси · doi:10.34883/pi.2021.13.2.013
PHARMACOGENETIC TESTING AS AN ELEMENT OF PERSONALIZED MEDICINE IN REAL CLINICAL PRACTICE
Бартенева, А. С., & Vorobyeva, N. A. (2022) · Russian Journal for Personalized Medicine · doi:10.18705/2782-3806-2022-2-3-27-37
Mansur, A. J. (2023) · International Journal of Cardiovascular Sciences · doi:10.36660/ijcs.20230095
Aynal, F., & Arslan, S. (2025) · Journal of Vascular Nursing · doi:10.1016/j.jvn.2025.01.004
Jiraporncharoen, W., Buawangpong, N., Angkurawaranon, C., Jolly, K. B., Thomas, G. N., Phrommintikul, A., Krittayaphong, R., Nathisuwan, S., Lip, G. Y. H., Lane, D. A., et al. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-096490
Self-citationvan der Horst, S. F. B., van den Bemt, B. J. F., Chu, K. G., Seelig, J., Trinks-Roerdink, E. M., Voorhout, L., de Vries, T. A. C., van Alem, A. P., Beukema, R. J., Boersma, L. V. A., et al. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5220813
da Silva, M. V. B., Pereira, N. D. S., Queiroz, X. S. B. A., da Silveira, M. M. B. M., & Bezerra, S. M. M. D. S. (2025) · Journal of Vascular Nursing · doi:10.1016/j.jvn.2025.07.003
Rivera‐Caravaca, J. M., Menichelli, D., Pastori, D., Soler‐Espejo, E., Esteve‐Pastor, M. A., Vivas, D., Roldán, I., Anguita, M. P., Ferreiro, J. L., Roldán, V., et al. (2025) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2025.107031
Atrial fibrillation and primary care prevention and rehabilitation – a feasibility study
Elnegaard, C. M., Pedersen, M. K., Zwisler, A., Borregaard, B., Eilsø, J. F., Sommer, T., Tveskov, C., Hendriks, J., Brandes, A., & Risom, S. S. (2025) · Pilot and Feasibility Studies · doi:10.1186/s40814-025-01724-3
Paschoal, E., Gooden, T. E., Olmos, R. D., Lotufo, P. A., Benseñor, I. M., Manaseki-Holland, S., Lip, G. Y. H., Thomas, G. N., Jolly, K., Lancashire, E. R., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22599712
Self-citation
Metadata
- Authors
- Clarkesmith, D. E., Pattison, H. M., Lip, G. Y. H., & Lane, D. A.
- Affiliations
- Aston University (GB)
- Birmingham City Hospital (GB)
- Corresponding author
- Lane, Deirdre A.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-09-09
- Volume
- 8
- Issue
- 9
- Pages
- e74037
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3767671
- OpenAlex
- W2045883381
- Cited by
- 209
- References
- 45
- Citations by year
- 2026: 5 · 2025: 8 · 2024: 6 · 2023: 14 · 2022: 14 · 2021: 19 · 2020: 21 · 2019: 17 · 2018: 20 · 2017: 31 · 2016: 24 · 2015: 19 · 2014: 11
- FWCI
- 12.25
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Aston Publications Explorer (Aston University) (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Funders
- Pfizer
- Sanofi
- Bayer HealthCare
- University of Birmingham
- Daiichi-Sankyo
- Astellas Pharma
- Aston University
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
- Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
- Health Sciences › Health Professions › Pharmacy › Pharmacy and Medical Practices
- Keywords
- atrial fibrillation, warfarin, anticoagulation management, time in therapeutic range, patient education, educational intervention, stroke prevention, patient knowledge, illness perception, medication beliefs, medication adherence, quality of life, anxiety and depression, theory-based intervention, TREAT trial, patient-centered care
- MeSH terms
- Aged, Aged, 80 and over, Anticoagulants, Anxiety, Atrial Fibrillation, Culture, Depression, Female, Humans, Health Knowledge, Attitudes, Practice, Male, Middle Aged, Patient Education as Topic, Perception, Quality of Life, Time Factors, International Normalized Ratio, Stroke, Medication Adherence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
